Form 4 for ARDX ARDELYX, INC.
Accepted 2024-05-07 00:00:00 ET · period of report 2024-05-03 · accession 0001610717-24-000230 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-05-07 | 2024-05-03 | ARDX | Williams Laura A | Chief Medical Off | M - OptEx | $0.99 | +30.0K | 410.1K | +8% | +$29.7K |
| DT | 2024-05-07 | 2024-05-03 | ARDX | Williams Laura A | Chief Medical Off | S - Sale+OE | $8.35 | -39.9K | 370.2K | -10% | -$333.6K |
| DT | 2024-05-07 | 2024-05-03 | ARDX | Williams Laura A | Chief Medical Off | M - OptEx | $0.00 | -30.0K | 162.0K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-03 | M | A | 30,000 | $0.99 | 410,138 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-03 | S | D | 39,949 | $8.35 | 370,189 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-05-03 | M | D | 30,000 | $0.00 | 162,000 | D | $0.99 · — to 2032-01-06 | 30,000 Common Stock | (F2) The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. |